These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20230782)

  • 41. Human importin alpha and RNA do not compete for binding to influenza A virus nucleoprotein.
    Boulo S; Akarsu H; Lotteau V; Müller CW; Ruigrok RW; Baudin F
    Virology; 2011 Jan; 409(1):84-90. PubMed ID: 20974480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Complete oligomerization of the nucleoprotein and various strains of influenza virus].
    Semenova NP; Prokudina EN; Chumakov VM
    Mol Gen Mikrobiol Virusol; 1996; (3):11-6. PubMed ID: 8999311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping the phosphoprotein binding site on Sendai virus NP protein assembled into nucleocapsids.
    Cevik B; Kaesberg J; Smallwood S; Feller JA; Moyer SA
    Virology; 2004 Aug; 325(2):216-24. PubMed ID: 15246262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment.
    Hanke L; Knockenhauer KE; Brewer RC; van Diest E; Schmidt FI; Schwartz TU; Ploegh HL
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
    Li S; Min JY; Krug RM; Sen GC
    Virology; 2006 May; 349(1):13-21. PubMed ID: 16466763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
    Oukka M; Manuguerra JC; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K
    J Immunol; 1996 Oct; 157(7):3039-45. PubMed ID: 8816413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates.
    Vreede FT; Jung TE; Brownlee GG
    J Virol; 2004 Sep; 78(17):9568-72. PubMed ID: 15308750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of the isolation technique of influenza virus nucleoprotein on its antigenic properties.
    Khristova ML; Egorenkova EM; Zagidullin NV; Sokolova MV; Busse TL; Leonov SV; Kharitonenkov IG
    Acta Virol; 1987 Aug; 31(4):289-97. PubMed ID: 2892378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus.
    Dilly S; Fotso Fotso A; Lejal N; Zedda G; Chebbo M; Rahman F; Companys S; Bertrand HC; Vidic J; Noiray M; Alessi MC; Tarus B; Quideau S; Riteau B; Slama-Schwok A
    J Med Chem; 2018 Aug; 61(16):7202-7217. PubMed ID: 30028133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza nucleoprotein: promising target for antiviral chemotherapy.
    Cianci C; Gerritz SW; Deminie C; Krystal M
    Antivir Chem Chemother; 2012 Jul; 23(3):77-91. PubMed ID: 22837443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
    Qing M; Liu W; Yuan Z; Gu F; Shi PY
    Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
    Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
    Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure and sequence analysis of influenza A virus nucleoprotein.
    Ng AK; Wang JH; Shaw PC
    Sci China C Life Sci; 2009 May; 52(5):439-49. PubMed ID: 19471866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of an RNA binding region within the N-terminal third of the influenza A virus nucleoprotein.
    Albo C; Valencia A; Portela A
    J Virol; 1995 Jun; 69(6):3799-806. PubMed ID: 7745727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Development of anti-influenza drug].
    Zhang T; Wang CY; Gao YW; Yang ST; Wang TC; Xia XZ
    Bing Du Xue Bao; 2011 Sep; 27(5):475-80. PubMed ID: 21998961
    [No Abstract]   [Full Text] [Related]  

  • 57. Location and architecture of an antibody-binding site of influenza A virus nucleoprotein.
    Varich NL; Sadykova GK; Prilipov AG; Kochergin-Nikitsky KS; Webster RG; Kaverin NV
    Arch Virol; 2014 Jun; 159(6):1493-7. PubMed ID: 24357080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The N terminus of the influenza B virus nucleoprotein is essential for virus viability, nuclear localization, and optimal transcription and replication of the viral genome.
    Sherry L; Smith M; Davidson S; Jackson D
    J Virol; 2014 Nov; 88(21):12326-38. PubMed ID: 25122787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-based virtual screening and experimental validation of the discovery of inhibitors targeted towards the human coronavirus nucleocapsid protein.
    Chang CK; Jeyachandran S; Hu NJ; Liu CL; Lin SY; Wang YS; Chang YM; Hou MH
    Mol Biosyst; 2016 Jan; 12(1):59-66. PubMed ID: 26542199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The N-terminal extension of the influenza B virus nucleoprotein is not required for nuclear accumulation or the expression and replication of a model RNA.
    Stevens MP; Barclay WS
    J Virol; 1998 Jun; 72(6):5307-12. PubMed ID: 9573310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.